Hussein Abdul-Hassan Tawbi, MD
Professor, Melanoma Medical Oncology, UT MD Anderson Cancer Center (The University of Texas MD Anderson Cancer Center)
General Internal Medicine
The goal of this activity is for learners to be better able to recognize the role of LAG3 inhibitors in melanoma treatment, with a focus on understanding the patient’s experience, clinical decision-making, and application to practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
IPCE CreditsUp to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 credits
MOC types
ABIM — Medical KnowledgeUp to 0.75 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
300 of a sample of 300 are free · 1,268 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Clinical Informatics
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Obstetrics & Gynecology
- Ophthalmology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Neurology
- Plastic & Reconstructive Surgery
- Preventive Medicine
- Primary Care Sports Medicine
- Pulmonary Disease
- Rheumatology
- Rhinology
- Sleep Medicine
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Faculty 1
All faculty
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
- Commercial Support
-
ReleasedMar 6, 2026
-
Last day to claim creditMar 7, 2027 5 months left
-
PRIME Education, Inc. (PRIME®) Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma
-
Answers in CME Inc. (AiCME) Post ESMO Update: Enhancing First-Line Treatment Selection in Advanced Melanoma: A Patient-Centered Approach
-
PVI, PeerView Institute for Medical Education Collaborating to Change the Clinical Course: Multidisciplinary Perspectives on Early-Stage Melanoma Management
